Sun Pharma gets USFDA approval for Accupril; stk down

Published on Mon, Jun 22, 2009 at 12:31 |  Source : Moneycontrol.com

Updated at Mon, Jun 22, 2009 at 12:33  

24316 Investors following Sun Pharma. Share this News with them.
0
0
Share on Tumblr
Sun Pharma gets USFDA approval for Accupril; stk down

ALSO READ

Sun Pharmaceutical Industries touched an intraday high of Rs 1,330 and an intraday low of Rs 1,268.05. At 12:26 pm, the share was quoting at Rs 1,279.80, down Rs 33.75, or 2.57%.

The company has got USFDA approval for generic Accupril tablets, reports CNBC-TV18.
 
It was trading with volumes of 8,225 shares. On Friday the share closed down 0.24% or Rs 3.10 at Rs 1,313.55.

Share Price Movement During The Last 12 Months
Period Price Latest Price Gain/Loss (Rs.) % Gain/Loss
3-Days 1296.70 1279.80 -16.90 -1.30
5-Days 1279.30 1279.80 0.50 0.04
7-Days 1318.15 1279.80 -38.35 -2.91
15-Days 1306.65 1279.80 -26.85 -2.05
1-Month 1377.65 1279.80 -97.85 -7.10
3-Month 1020.10 1279.80 259.70 25.46
6-Month 1088.05 1279.80 191.75 17.62
9-Month 1393.05 1279.80 -113.25 -8.13
1-Year 1486.15 1279.80 -206.35 -13.88

 

  

More on Moneycontrol

Trending News

Business News

Top smartphones under Rs. 15,000
Rupee rally may stall with fall against US dollar, euro "Rupee rally may stall with fall against US dollar, euro"

2G Meet CNBC-TV18 ALERT PM Meets Pranab Mukherjee, Salman Khurshid & Kapil Sibal

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com